OTCs Are 'Sweet Spot' For Independent Pharmacies
This article was originally published in The Tan Sheet
Executive Summary
Overall sales at the roughly 24,000 independent US pharmacies are $81.4bn annually, with front-of-store sales of OTC and beauty items accounting for around 10%. Higher OTC sales can help independent pharmacies make up for major chain pharmacies getting most Rx drug sales.
You may also be interested in...
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.
MoCRA Implementation In US Election Year: Q&A With Attorney Wade Ackerman
Wade Ackerman, partner at Covington & Burling who served previously as senior FDA counsel to US Senate Health Education, Labor & Pensions (HELP) Committee leadership, discusses expectations for FDA activity under modernized cosmetics regulations in 2024.
Ulta’s Footprint Will Grow From US To Mexico In 2025 Under Axo Partnership
Bolingbrook, Ill.-based Ulta Beauty, Inc. will make its international debut in Mexico, a "sizable, growing” market that represents "significant beauty opportunity," says CEO David Kimbell in the firm’s a fiscal 2023 fourth-quarter earnings presentation.